Literature DB >> 29358272

FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta.

Mathilde Doyard1, Séverine Bacrot1, Céline Huber1, Maja Di Rocco2, Alice Goldenberg3, Mona S Aglan4, Perrine Brunelle1, Samia Temtamy4, Caroline Michot1, Ghada A Otaify4, Coralie Haudry1, Mireille Castanet5, Julien Leroux6, Jean-Paul Bonnefont1, Arnold Munnich1, Geneviève Baujat1, Pablo Lapunzina7,8, Sophie Monnot1, Victor L Ruiz-Perez8,9, Valérie Cormier-Daire1.   

Abstract

BACKGROUND: Stüve-Wiedemann syndrome (SWS) is characterised by bowing of the lower limbs, respiratory distress and hyperthermia that are often responsible for early death. Survivors develop progressive scoliosis and spontaneous fractures. We previously identified LIFR mutations in most SWS cases, but absence of LIFR pathogenic changes in five patients led us to perform exome sequencing and to identify homozygosity for a FAM46A mutation in one case [p.Ser205Tyrfs*13]. The follow-up of this case supported a final diagnosis of osteogenesis imperfecta (OI), based on vertebral collapses and blue sclerae. METHODS AND
RESULTS: This prompted us to screen FAM46A in 25 OI patients with no known mutations.We identified a homozygous deleterious variant in FAM46A in two affected sibs with typical OI [p.His127Arg]. Another homozygous variant, [p.Asp231Gly], also classed as deleterious, was detected in a patient with type III OI of consanguineous parents using homozygosity mapping and exome sequencing.FAM46A is a member of the superfamily of nucleotidyltransferase fold proteins but its exact function is presently unknown. Nevertheless, there are lines of evidence pointing to a relevant role of FAM46A in bone development. By RT-PCR analysis, we detected specific expression of FAM46A in human osteoblasts andinterestingly, a nonsense mutation in Fam46a has been recently identified in an ENU-derived (N-ethyl-N-nitrosourea) mouse model characterised by decreased body length, limb, rib, pelvis, and skull deformities and reduced cortical thickness in long bones.
CONCLUSION: We conclude that FAM46A mutations are responsible for a severe form of OI with congenital bowing of the lower limbs and suggest screening this gene in unexplained OI forms. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  calcium and bone; clinical genetics; developmental

Mesh:

Substances:

Year:  2018        PMID: 29358272     DOI: 10.1136/jmedgenet-2017-104999

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  22 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

Review 2.  A tale of non-canonical tails: gene regulation by post-transcriptional RNA tailing.

Authors:  Sha Yu; V Narry Kim
Journal:  Nat Rev Mol Cell Biol       Date:  2020-06-01       Impact factor: 94.444

Review 3.  Osteogenesis imperfecta: an update on clinical features and therapies.

Authors:  Ronit Marom; Brien M Rabenhorst; Roy Morello
Journal:  Eur J Endocrinol       Date:  2020-10       Impact factor: 6.664

4.  Protein-coding repeat polymorphisms strongly shape diverse human phenotypes.

Authors:  Ronen E Mukamel; Robert E Handsaker; Maxwell A Sherman; Alison R Barton; Yiming Zheng; Steven A McCarroll; Po-Ru Loh
Journal:  Science       Date:  2021-09-23       Impact factor: 47.728

5.  Patient-reported outcomes in a Chinese cohort of osteogenesis imperfecta unveil psycho-physical stratifications associated with clinical manifestations.

Authors:  Peikai Chen; Zhijia Tan; Anmei Qiu; Shijie Yin; Yapeng Zhou; Zhongxin Dong; Yan Qiu; Jichun Xu; Kangsen Li; Lina Dong; Hiu Tung Shek; Jingwen Liu; Eric H K Yeung; Bo Gao; Kenneth Man Chee Cheung; Michael Kai-Tsun To
Journal:  Orphanet J Rare Dis       Date:  2022-06-28       Impact factor: 4.303

Review 6.  Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.

Authors:  Milena Jovanovic; Gali Guterman-Ram; Joan C Marini
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

7.  Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease.

Authors:  Scott E Youlten; John P Kemp; John G Logan; Elena J Ghirardello; Claudio M Sergio; Michael R G Dack; Siobhan E Guilfoyle; Victoria D Leitch; Natalie C Butterfield; Davide Komla-Ebri; Ryan C Chai; Alexander P Corr; James T Smith; Sindhu T Mohanty; John A Morris; Michelle M McDonald; Julian M W Quinn; Amelia R McGlade; Nenad Bartonicek; Matt Jansson; Konstantinos Hatzikotoulas; Melita D Irving; Ana Beleza-Meireles; Fernando Rivadeneira; Emma Duncan; J Brent Richards; David J Adams; Christopher J Lelliott; Robert Brink; Tri Giang Phan; John A Eisman; David M Evans; Eleftheria Zeggini; Paul A Baldock; J H Duncan Bassett; Graham R Williams; Peter I Croucher
Journal:  Nat Commun       Date:  2021-05-05       Impact factor: 14.919

8.  Novel mutations in BMP1 result in a patient with autosomal recessive osteogenesis imperfecta.

Authors:  Lei Xi; Shanshan Lv; Hao Zhang; Zhen-Lin Zhang
Journal:  Mol Genet Genomic Med       Date:  2021-04-05       Impact factor: 2.183

9.  Overexpression of FAM46A, a Non-canonical Poly(A) Polymerase, Promotes Hemin-Induced Hemoglobinization in K562 Cells.

Authors:  Hsi-Hsien Lin; Yu-Ling Lo; Wen-Chih Wang; Kuan-Yeh Huang; Kuan-Yu I; Gin-Wen Chang
Journal:  Front Cell Dev Biol       Date:  2020-05-26

Review 10.  Collagen transport and related pathways in Osteogenesis Imperfecta.

Authors:  Lauria Claeys; Silvia Storoni; Marelise Eekhoff; Mariet Elting; Lisanne Wisse; Gerard Pals; Nathalie Bravenboer; Alessandra Maugeri; Dimitra Micha
Journal:  Hum Genet       Date:  2021-06-24       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.